Hypertension
Conditions
Keywords
Hypertension, High blood pressure, Task shifting, Decision support system
Brief summary
This study evaluates the effect of a mobile health technology enabled trained nurse led intervention on control of blood pressure among patients with hypertension seeking care in the community health centres in the southern state of Andhra Pradesh, India. half the community health centres will receive the intervention and the other half will receive the routine care.
Detailed description
The burden of hypertension is very high in India but the control rates of hypertension are very low. One of the important reasons for this is the lack of awareness and the inability of the doctors working in busy out patient settings of public health facilities to care adequately for the patients. Hence there is a need for task shifting. In this trial a trained nurse care coordinator will be placed in the Community Health Centres (CHCs) and she will be provided with an Electronic Decision Support System (EDSS), in the form of an android application installed on a tablet, to treat hypertension. The trial will be carried out in twelve CHCs of Visakhapatnam district in southern Indian state of Andhra Pradesh.
Interventions
OTHERIntervention
A trained nurse care coordinator enabled with a electronic decision support system placed at the CHCs to share the task of management of hypertension.
OTHERControl
No NCC or EDSS will be placed in the CHCs. Doctors working in the CHCs will be given training (one day) on evidence based management of hypertension
Sponsors
All India Institute of Medical Sciences
Indian Council of Medical Research
Centre for Chronic Disease Control, India
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Participants aged ≥30 years. 2. Willing to provide written informed consent for the study. 3. Identified as suffering from hypertension (≥160/100 mmHg) with or without co-morbidities such as left ventricular hypertrophy, heart failure, coronary artery disease, peripheral vascular disease, or diabetes mellitus
Exclusion criteria
1. Participants aged \<30years 2. Unwilling/unable to provide written informed consent for the study 3. Having malignancies or life threatening conditions 4. Currently participating in other clinical trials 5. Those with plans to move residence in the year ahead.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Difference in the mean systolic blood pressure | 12 months | Difference in the mean systolic blood pressure between the intervention and control arm at the end of the intervention |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Compliance to therapy | 12 months | Difference in compliance to therapy from baseline to one year between the intervention and control arm |
| Follow up with the physician | 12 months | Difference in follow up rate from baseline to one year between the intervention and control arm |
Countries
India
Outcome results
None listed